Related Experiment Video

Updated: Sep 2, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

583

Three-year disease-free remission in a xeroderma pigmentosum patient after adjuvant anti-PD-1 therapy

Valerie Scheer1, Oliver Schmalz2, Percy Lehmann1

  • 1Department of Dermatology, Allergology and Dermatosurgery, Helios University Hospital Wuppertal, University Witten/Herdecke, Germany.

European Journal of Cancer (Oxford, England : 1990)
|August 4, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.3K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.5K

Related Experiment Videos

Last Updated: Sep 2, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

583
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.3K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.5K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

Articles linked to this work by shared authors, journal, and citation graph.

Trust in skincare and topical therapies in atopic dermatitis or psoriasis: a German cross-sectional study.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Treatment Preferences Among Systemic Therapy-Naïve Patients with Atopic Dermatitis or Psoriasis in Germany: A Multicentre Study.

Dermatology and therapy·2025

Avapritinib reduces symptoms and mast cell burden in systemic mastocytosis.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2025

[Trichophyton mentagrophytes ITS genotype VIII/Trichophyton indotineae in Germany-revisit after 5 years].

Dermatologie (Heidelberg, Germany)·2025

Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study.

Digital health·2025

Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial.

Blood neoplasia·2025

70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups.

European journal of cancer (Oxford, England : 1990)·2026

Access to early-phase oncology trials: Trajectories and outcomes of more than 26,000 patients referred to a high-volume phase I unit.

European journal of cancer (Oxford, England : 1990)·2026

Genomic landscape of sweat gland carcinomas: Clinical applications and future directions.

European journal of cancer (Oxford, England : 1990)·2026

Organ-preserving surgery for solid pseudopapillary neoplasm of the pancreas: A multicentric study.

European journal of cancer (Oxford, England : 1990)·2026

Sentinel lymph node biopsy in melanoma: Redundant in the neoadjuvant era.

European journal of cancer (Oxford, England : 1990)·2026

Triplet chemotherapy with Gemcitabine, Nab-paclitaxel, and S-1 achieves high response and conversion rates in advanced pancreatic cancer: A multicenter phase II study (GeNeS1S trial).

European journal of cancer (Oxford, England : 1990)·2026

Establishing a precision reference benchmark for corneal epithelial aberration measurements using a new hybrid device across keratoconus stages.

Eye and vision (London, England)·2026

Multicolor room-temperature phosphorescent carbon dots for information encryption prepared by modifying the amino substitution sites of precursors.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

Heteroleptic Cr4+ molecular color center candidates.

Chemical science·2026

Manipulation of waves in Polariton Topological Insulators.

Journal of physics. Condensed matter : an Institute of Physics journal·2026

Close Encounters between Periodic Light and Periodic Arrays of Quantum Emitters.

Physical review letters·2026

Linking acoustic waves and polymer deformation to reveal energy transmission pathways.

Soft matter·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us